Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(4.15)
Main Sectors:
Top Industries:
17 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CTMX CytomX Therapeutics | Initiates Coverage On: Overweight | 6 | 2.9 | 106.9% | 1 | Sep 22, 2025 | |
GOSS Gossamer Bio | Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 11, 2025 | |
UTHR United Therapeutics | Maintains: Overweight | 405 525 | 432.64 | 21.35% | 2 | Sep 10, 2025 | |
VRNA Verona Pharma | Maintains: Overweight | 90 100 | 106.69 | -6.27% | 1 | Jun 11, 2025 | |
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 5.1 | 154.9% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 90 90 | 53.85 | 67.13% | 15 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 480 480 | 385.74 | 24.44% | 22 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 55 | 44.1 | 24.72% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 80 | 112.1 | -28.64% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 563.9 | 80% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 272.98 | 48.36% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 446.4 | -50.72% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 13.14 | -23.9% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 5.53 | 17.54% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 61.67 | 16.75% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |